XML 33 R16.htm IDEA: XBRL DOCUMENT
v3.21.2

Fda Refund | 12 Months Ended
--- | ---
Sep. 30, 2021
Fda Refund Disclosure [Abstract] |
FDA REFUND | 9. FDA REFUND In November 2019, the Company received a $110,207 refund from the FDA for 2016 product and establishment fees because the fees paid by the Company exceeded the costs of the FDA’s review of the associated applications. The Company recorded the $110,207 as other income during the year ended September 30, 2020.

X
- References No definition available. + Details
Name: | ctxr_FdaRefundDisclosureAbstract
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ctxr_FdaRefundDisclosureTextBlock
Namespace Prefix: | ctxr_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration